ESC 365 - Long-term evolution of Fabry cardiomyopathy under enzyme replacement therapy in the Swiss Fabry cohort. An echocardiographic study

ESC Premium Access

Long-term evolution of Fabry cardiomyopathy under enzyme replacement therapy in the Swiss Fabry cohort. An echocardiographic study

Session: Poster Session 1 - Inflammatory, infiltrative and cardiomyopathy

Topic: Infiltrative Myocardial Disease

Speaker: Doctor P. Monney (Lausanne, CH)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Pierre Monney

University Hospital Centre Vaudois (CHUV), Lausanne (Switzerland)

2 presentations

0 follower

9 more presentations in this session

Apical sparing in patients without cardiac amyloidosis

Speaker: Ms C. Binder (Vienna, AT)

Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy

Speaker: Doctor R. Rettl (Vienna, AT)

Diagnostic utility of tissue biopsy in transthyretin cardiac amyloidosis diagnosed by non-invasive diagnostic criteria

Speaker: Doctor M. Nishi (Kumamoto, JP)

Association of acroparesthesias and angiokeratomas with the alpha-galactosidase A gene polymorphisms in females with hypertrophic cardiomyopathy

Speaker: Miss A. Polyakova (Saint Petersburg, RU)

Electrocardiographic findings in Anderson-Fabry disease versus sarcomeric hypertrophic cardiomyopathy

Speaker: Doctor G. Vitale (Bologna, IT)

Access the full session

Poster Session 1 - Inflammatory, infiltrative and cardiomyopathy

Speakers: Doctor P. Monney, Ms C. Binder, Doctor R. Rettl, Doctor M. Nishi, Miss A. Polyakova...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources